behavior/neurological
• mice show severe neurological impairments from 4 months of age
|
• hind-limb clasping from 4 months of age
|
growth/size/body
• reduction in body weight at 10 months of age
|
hematopoietic system
microgliosis
(
J:216676
)
• progressive increase in microgliosis in the pons and midbrain
|
homeostasis/metabolism
• beta-glucocerebrosidase activity is reduced in the pons and midbrain
• beta-hexosaminidase and alpha-mannosidase activities are increased in the brain
|
immune system
microgliosis
(
J:216676
)
• progressive increase in microgliosis in the pons and midbrain
|
mortality/aging
• do not survive beyond 10 months of age
|
nervous system
• accumulation of alpha-synuclein in the pons and midbrain, including the substantia nigra
|
microgliosis
(
J:216676
)
• progressive increase in microgliosis in the pons and midbrain
|
astrocytosis
(
J:216676
)
• progressive increase in astrogliosis in the pons and midbrain
|
• accumulation of storage material within the neurons of the pons; presence of electron-dense material, lipid droplets, and lamellated bodies
• progressive storage of carbohydrate conjugates, particularly in the pons, including intracellular accumulation of the beta-glucocerebrosidase substrate, GluCer, and accumulation of vesicular alpha-synuclein in the soma and proximal neurites of neurons
|
• tyrosine-hydroxylase (TH)-positive neurons within the substantia nigra are shrunken in size
• progressive apoptotic cell death in the pons and midbrain
• neurodegeneration of dopaminergic neurons
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
progressive myoclonus epilepsy | DOID:891 |
OMIM:310370 OMIM:PS254800 |
J:216676 |